{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:22:05Z","timestamp":1777951325084,"version":"3.51.4"},"update-to":[{"DOI":"10.1016\/j.jhsa.2025.03.013","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000}}],"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhandsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Hand Surgery"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jhsa.2025.03.013","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T07:19:33Z","timestamp":1747293573000},"page":"312.e1-312.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["RETRACTED: The Impact of Emerging Therapies and Declining Physician Reimbursement on Dupuytren Disease Treatment: A 21-Year Review"],"prefix":"10.1016","volume":"51","author":[{"given":"Evan H.","family":"Richman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dylan","family":"Rakowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Lauder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jhsa.2025.03.013_bib1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/PRS.0b013e3182958a33","article-title":"Prevalence of dupuytren disease in the Netherlands","volume":"132","author":"Lanting","year":"2013","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.jhsa.2025.03.013_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s13018-020-01999-7","article-title":"The worldwide prevalence of the Dupuytren disease: a comprehensive systematic review and meta-analysis","volume":"15","author":"Salari","year":"2020","journal-title":"J Orthop Surg Res"},{"issue":"4","key":"10.1016\/j.jhsa.2025.03.013_bib3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2106\/00004623-195941040-00008","article-title":"Dupuytren\u2019s contracture: a new concept of the pathogenesis correlated with surgical management","volume":"41-A","author":"Luck","year":"1959","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"10.1016\/j.jhsa.2025.03.013_bib4","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.ST.18.00047","article-title":"Percutaneous needle fasciotomy for Dupuytren contracture","volume":"9","author":"Str\u00f6mberg","year":"2019","journal-title":"JBJS Essent Surg Tech"},{"issue":"4","key":"10.1016\/j.jhsa.2025.03.013_bib5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jhsa.2012.01.029","article-title":"Results of needle aponeurotomy for dupuytren contracture in over 1,000 fingers","volume":"37","author":"Pess","year":"2012","journal-title":"J Hand Surg Am"},{"issue":"10","key":"10.1016\/j.jhsa.2025.03.013_bib6","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJMoa0810866","article-title":"Injectable collagenase clostridium histolyticum for Dupuytren\u2019s contracture","volume":"361","author":"Hurst","year":"2009","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jhsa.2025.03.013_bib7","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.jhsa.2010.08.007","article-title":"Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren\u2019s disease","volume":"35","author":"Gilpin","year":"2010","journal-title":"J Hand Surg Am"},{"issue":"3","key":"10.1016\/j.jhsa.2025.03.013_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jhsa.2021.11.019","article-title":"Five-year results of a randomized, controlled trial of collagenase treatment compared with needle fasciotomy for Dupuytren contracture","volume":"47","author":"Bystr\u00f6m","year":"2022","journal-title":"J Hand Surg Am"},{"issue":"5","key":"10.1016\/j.jhsa.2025.03.013_bib10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jhsa.2017.03.003","article-title":"Injectable collagenase versus percutaneous needle fasciotomy for dupuytren contracture in proximal interphalangeal joints: a randomized controlled trial","volume":"42","author":"Skov","year":"2017","journal-title":"J Hand Surg Am"},{"issue":"1","key":"10.1016\/j.jhsa.2025.03.013_bib11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/bmb\/ldw020","article-title":"Collagenase clostridium histolyticum in Dupuytren\u2019s contracture: a systematic review","volume":"118","author":"Smeraglia","year":"2016","journal-title":"Br Med Bull"},{"key":"10.1016\/j.jhsa.2025.03.013_bib13","first-page":"e15","article-title":"Surgical complications associated With fasciectomy for Dupuytren\u2019s disease: a 20-year review of the English literature","volume":"10","author":"Denkler","year":"2010","journal-title":"Eplasty"},{"issue":"2","key":"10.1016\/j.jhsa.2025.03.013_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/1753193414528843","article-title":"Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren\u2019s contracture","volume":"40","author":"Peimer","year":"2015","journal-title":"J Hand Surg Eur Vol"},{"issue":"4","key":"10.1016\/j.jhsa.2025.03.013_bib15","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00264-017-3690-0","article-title":"Factors influencing recurrence and progression of Dupuytren\u2019s disease treated by collagenase clostridium histolitycum","volume":"42","author":"Sim\u00f3n-P\u00e9rez","year":"2018","journal-title":"Int Orthop"},{"issue":"6","key":"10.1016\/j.jhsa.2025.03.013_bib16","first-page":"642","article-title":"A 10-year review of collagenase versus fasciectomy in the treatment of Dupuytren contracture","volume":"92","author":"Steppe","year":"2024","journal-title":"Ann Plast Surg"},{"issue":"4","key":"10.1016\/j.jhsa.2025.03.013_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.5312\/wjo.v15.i4.355","article-title":"Long-term assessment of collagenase treatment for Dupuytren\u2019s contracture: A 10-year follow-up study","volume":"15","author":"Passiatore","year":"2024","journal-title":"World J Orthop"},{"issue":"9-10","key":"10.1016\/j.jhsa.2025.03.013_bib18","doi-asserted-by":"crossref","first-page":"e2975","DOI":"10.1093\/milmed\/usad075","article-title":"Dupuytren\u2019s contracture recurrence and treatment following collagenase clostridium histolyticum injection: a longitudinal assessment in a Veteran population","volume":"188","author":"Zarb","year":"2023","journal-title":"Mil Med"},{"issue":"8","key":"10.1016\/j.jhsa.2025.03.013_bib19","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.jhsa.2015.04.036","article-title":"Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-year data","volume":"40","author":"Peimer","year":"2015","journal-title":"J Hand Surg Am"},{"issue":"22","key":"10.1016\/j.jhsa.2025.03.013_bib20","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2106\/JBJS.24.01104","article-title":"In treatment-na\u00efve Dupuytren contracture, surgery had a higher success rate at 2 years than needle fasciotomy or collagenase injection","volume":"106","author":"McCollam","year":"2024","journal-title":"J Bone Joint Surg Am"},{"issue":"3","key":"10.1016\/j.jhsa.2025.03.013_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012943","article-title":"Collagenase injections for Dupuytren\u2019s disease: prospective cohort study assessing 2-year treatment effect durability","volume":"7","author":"Lauritzson","year":"2017","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.jhsa.2025.03.013_bib22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1055\/s-0040-1721876","article-title":"Percutaneous needle fasciotomy versus collagenase injection for dupuytren\u2019s contracture: a systematic review of comparative studies","volume":"13","author":"Hirase","year":"2021","journal-title":"J Hand Microsurg"},{"issue":"13","key":"10.1016\/j.jhsa.2025.03.013_bib23","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2106\/JBJS.17.01128","article-title":"Percutaneous needle fasciotomy versus collagenase treatment for dupuytren contracture: A randomized controlled trial with a two-year follow-up","volume":"100","author":"Str\u00f6mberg","year":"2018","journal-title":"J Bone Joint Surg Am"},{"issue":"9","key":"10.1016\/j.jhsa.2025.03.013_bib24","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jhsa.2016.06.014","article-title":"Comparison of treatment outcome after collagenase and needle fasciotomy for dupuytren contracture: a randomized, single-blinded, clinical trial with a 1-year follow-up","volume":"41","author":"Str\u00f6mberg","year":"2016","journal-title":"J Hand Surg Am"},{"issue":"12","key":"10.1016\/j.jhsa.2025.03.013_bib25","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jhsa.2023.08.008","article-title":"Collagenase treatment versus needle fasciotomy for single-digit Dupuytren contractures: a meta-analysis of randomized controlled trials","volume":"48","author":"Zhang","year":"2023","journal-title":"J Hand Surg Am"},{"issue":"10","key":"10.1016\/j.jhsa.2025.03.013_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.19861","article-title":"Cost-effectiveness of recurrent Dupuytren contracture treatment","volume":"3","author":"Yoon","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.jhsa.2025.03.013_bib27","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.jhsa.2011.08.004","article-title":"Cost-effectiveness of open partial fasciectomy, needle aponeurotomy, and collagenase injection for dupuytren contracture","volume":"36","author":"Chen","year":"2011","journal-title":"J Hand Surg Am"},{"issue":"90","key":"10.1016\/j.jhsa.2025.03.013_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19900","article-title":"Collagenase clostridium histolyticum for the treatment of Dupuytren\u2019s contracture: systematic review and economic evaluation","volume":"19","author":"Brazzelli","year":"2015","journal-title":"Health Technol Assess"},{"issue":"8","key":"10.1016\/j.jhsa.2025.03.013_bib29","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1302\/0301-620X.95B8.31822","article-title":"Cost-effectiveness in the management of Dupuytren\u2019s contracture. A Canadian cost-utility analysis of current and future management strategies","volume":"95-B","author":"Baltzer","year":"2013","journal-title":"Bone Joint J"},{"issue":"11","key":"10.1016\/j.jhsa.2025.03.013_bib30","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jhsa.2019.07.017","article-title":"Outcomes and direct costs of needle aponeurotomy, collagenase injection, and fasciectomy in the treatment of Dupuytren contracture","volume":"44","author":"Leafblad","year":"2019","journal-title":"J Hand Surg Am"},{"issue":"10","key":"10.1016\/j.jhsa.2025.03.013_bib31","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1016\/j.arth.2021.05.040","article-title":"Google trend analysis shows increasing public interest in platelet-rich plasma injections for hip and knee osteoarthritis","volume":"36","author":"Cohen","year":"2021","journal-title":"J Arthroplasty"},{"issue":"3-4","key":"10.1016\/j.jhsa.2025.03.013_bib32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000336533","article-title":"Science and the sources of hype","volume":"15","author":"Caulfield","year":"2012","journal-title":"Public Health Genomics"},{"issue":"2","key":"10.1016\/j.jhsa.2025.03.013_bib33","article-title":"Inflation-adjusted Medicare reimbursement has decreased for orthopaedic sports medicine procedures: analysis from 2000 to 2020","volume":"10","author":"Pollock","year":"2022","journal-title":"Orthop J Sport Med"},{"issue":"7S","key":"10.1016\/j.jhsa.2025.03.013_bib34","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.arth.2021.02.006","article-title":"Temporal analysis of Medicare physician reimbursement and procedural volume for all hip and knee arthroplasty procedures billed to Medicare Part B From 2000 to 2019","volume":"36","author":"Haglin","year":"2021","journal-title":"J Arthroplasty"},{"issue":"1","key":"10.1016\/j.jhsa.2025.03.013_bib35","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/JU.0000000000001655","article-title":"Declining Medicare Reimbursement for Urologists: An Opportunity for Informed Advocacy","volume":"206","author":"Edmonds","year":"2021","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.jhsa.2025.03.013_bib36","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1177\/1558944721990807","article-title":"An analysis of procedural Medicare reimbursement rates in hand surgery: 2000 to 2019","volume":"17","author":"Thornburg","year":"2022","journal-title":"Hand (N Y)"},{"issue":"11","key":"10.1016\/j.jhsa.2025.03.013_bib37","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jhsa.2020.08.010","article-title":"Declining trend in Medicare physician reimbursements for hand surgery from 2002 to 2018","volume":"45","author":"Malik","year":"2020","journal-title":"J Hand Surg Am"},{"issue":"24","key":"10.1016\/j.jhsa.2025.03.013_bib38","doi-asserted-by":"crossref","first-page":"e1396","DOI":"10.5435\/JAAOS-D-20-01369","article-title":"Temporal and geographic trends in medicare reimbursement of primary and revision shoulder arthroplasty: 2000 to 2020","volume":"29","author":"Testa","year":"2021","journal-title":"J Am Acad Orthop Surg"},{"issue":"1","key":"10.1016\/j.jhsa.2025.03.013_bib39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/15589447221096708","article-title":"Medicare reimbursement in hand and upper extremity procedures: a 20-year analysis","volume":"19","author":"Weiss","year":"2024","journal-title":"Hand (N Y)"},{"issue":"1","key":"10.1016\/j.jhsa.2025.03.013_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/689772","article-title":"In the shadow of a giant: Medicare\u2019s influence on private physician payments","volume":"125","author":"Clemens","year":"2017","journal-title":"J Polit Econ"},{"issue":"3","key":"10.1016\/j.jhsa.2025.03.013_bib41","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/PRS.0000000000009919","article-title":"Dupuytren disease: prevalence, incidence, and lifetime risk of surgical intervention. a population-based cohort analysis","volume":"151","author":"Broekstra","year":"2023","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.jhsa.2025.03.013_bib42","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/J.JHSB.2004.06.006","article-title":"Dupuytren\u2019s disease risk factors","volume":"29","author":"Geoghegan","year":"2004","journal-title":"J Hand Surg Br"}],"updated-by":[{"DOI":"10.1016\/j.jhsa.2025.03.013","type":"removal","label":"Removal","source":"publisher","updated":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000}},{"DOI":"10.1016\/j.jhsa.2025.03.013","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000}},{"DOI":"10.1016\/j.jhsa.2026.04.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000}}],"container-title":["The Journal of Hand Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0363502325001546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0363502325001546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T02:54:05Z","timestamp":1775616845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0363502325001546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0363502325001546"],"URL":"https:\/\/doi.org\/10.1016\/j.jhsa.2025.03.013","relation":{},"ISSN":["0363-5023"],"issn-type":[{"value":"0363-5023","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: The Impact of Emerging Therapies and Declining Physician Reimbursement on Dupuytren Disease Treatment: A 21-Year Review","name":"articletitle","label":"Article Title"},{"value":"The Journal of Hand Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhsa.2025.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Society for Surgery of the Hand. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}